Prelude Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Prelude Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-53,400	Closed	-$1.34M	–	2046
2017 Q2	$1.34M	Buy	53,400 +25,200	+89%	+$624K	0.13%	165
2017 Q1	$757K	Buy	28,200 +7,800	+38%	+$215K	0.07%	272
2016 Q4	$535K	Sell	20,400 -4,600	-18%	-$114K	0.06%	308
2016 Q3	$625K	Buy	+25,000	New	+$583K	0.07%	273

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Prelude Capital Management's NXTM Position: Q1 2019 in Review

Prelude Capital Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 78,032 shares — an estimated $2.23M sold.

Prelude Capital Management first reported a position in NXTM in Q2 2015 and held it in 8 quarters. The position peaked at $2.23M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Prelude Capital Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Prelude Capital Management sold 78,032 NxStage Medical Inc. shares in Q1 2019, an estimated $2.23M.
Prelude Capital Management first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 8 quarters.
Prelude Capital Management's NxStage Medical Inc. position peaked at $2.23M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.